These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 10515798)

  • 21. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border.
    Giuliano AR; Papenfuss M; Abrahamsen M; Inserra P
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):930-4. PubMed ID: 12223441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study.
    Goodman MT; Shvetsov YB; McDuffie K; Wilkens LR; Zhu X; Ning L; Killeen J; Kamemoto L; Hernandez BY
    J Infect Dis; 2008 Apr; 197(7):957-66. PubMed ID: 18429348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
    Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
    Herrero R; Castle PE; Schiffman M; Bratti MC; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Chen S; Rodriguez AC; Burk RD
    J Infect Dis; 2005 Jun; 191(11):1796-807. PubMed ID: 15871111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection and molecular typing of human papillomaviruses: prevalence of cervical infection in the Tunisian central region].
    Hassen E; Remadi S; Chouchane L
    Tunis Med; 1999 Oct; 77(10):497-502. PubMed ID: 10670281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of cervical human papillomavirus infection and types among women immigrated to Sicily, Italy.
    Giovannelli L; Vassallo R; Matranga D; Affronti M; Caleca MP; Bellavia C; Perino A; Ammatuna P
    Acta Obstet Gynecol Scand; 2009; 88(6):737-42. PubMed ID: 19412805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Human papillomavirus infection and other risk factors for cervical cancer in Chinese and Australian patients].
    Liu JH; Huang X; Liao GW; Li JD; Li YF; Li MD; Rose B; Thompson C
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):748-52. PubMed ID: 12899750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand.
    Sukvirach S; Smith JS; Tunsakul S; Muñoz N; Kesararat V; Opasatian O; Chichareon S; Kaenploy V; Ashley R; Meijer CJ; Snijders PJ; Coursaget P; Franceschi S; Herrero R
    J Infect Dis; 2003 Apr; 187(8):1246-56. PubMed ID: 12696004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
    Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon.
    Si-Mohamed A; Ndjoyi-Mbiguino A; Cuschieri K; Onas IN; Colombet I; Ozouaki F; Goff JL; Cubie H; Bélec L
    J Med Virol; 2005 Nov; 77(3):430-8. PubMed ID: 16173023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.
    Marais DJ; Passmore JA; Denny L; Sampson C; Allan BR; Williamson AL
    J Med Virol; 2008 Jun; 80(6):953-9. PubMed ID: 18428143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relative risk analysis of the development of cervical noncancer lesion and cervical carcinoma associated with HPV infection].
    Zhang W
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):300-3. PubMed ID: 8137414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.
    Brown DR; Shew ML; Qadadri B; Neptune N; Vargas M; Tu W; Juliar BE; Breen TE; Fortenberry JD
    J Infect Dis; 2005 Jan; 191(2):182-92. PubMed ID: 15609227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.
    Goodman MT; Shvetsov YB; McDuffie K; Wilkens LR; Zhu X; Thompson PJ; Ning L; Killeen J; Kamemoto L; Hernandez BY
    Cancer Res; 2008 Nov; 68(21):8813-24. PubMed ID: 18974124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
    Roset Bahmanyar E; Paavonen J; Naud P; Salmerón J; Chow SN; Apter D; Kitchener H; Castellsagué X; Teixeira JC; Skinner SR; Jaisamrarn U; Limson GA; Garland SM; Szarewski A; Romanowski B; Aoki F; Schwarz TF; Poppe WA; De Carvalho NS; Harper DM; Bosch FX; Raillard A; Descamps D; Struyf F; Lehtinen M; Dubin G;
    Gynecol Oncol; 2012 Dec; 127(3):440-50. PubMed ID: 22940493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.
    Louvanto K; Rautava J; Syrjänen K; Grénman S; Syrjänen S
    Clin Microbiol Infect; 2014 Nov; 20(11):1167-72. PubMed ID: 24890849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus infection is transient in young women: a population-based cohort study.
    Evander M; Edlund K; Gustafsson A; Jonsson M; Karlsson R; Rylander E; Wadell G
    J Infect Dis; 1995 Apr; 171(4):1026-30. PubMed ID: 7706782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.
    Videla S; Darwich L; Cañadas MP; Paredes R; Tarrats A; Castella E; Llatjos M; Bofill M; Clotet B; Sirera G;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):168-75. PubMed ID: 19131892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Human Papilloma virus. Epidemiologic, carcinogenic, diagnostic and therapeutic aspects].
    Vargas-Hernández VM
    Ginecol Obstet Mex; 1996 Sep; 64():411-7. PubMed ID: 8964543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Investigation of infection with human papillomavirus in areas of high and low incidences of cervical carcinoma in Sichuan Province].
    Tang XL
    Zhonghua Fu Chan Ke Za Zhi; 1992 Nov; 27(6):345-7, 379-80. PubMed ID: 1338628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.